BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, December 18, 2024
See today's BioWorld
Home
» Fund Pressures Actelion to Put Up a For-Sale Sign
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Fund Pressures Actelion to Put Up a For-Sale Sign
Feb. 9, 2011
By
Nuala Moran
No Comments
LONDON – The board of Actelion was forced to defend CEO Jean-Paul Clozel and deny it has received any offer to buy the company, following a demand from the U.S. hedge fund investor Elliott Advisors that it look for potential acquirers.
BioWorld